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INTRODUCTION
Celiac disease (CD) is an immune-mediated 
systemic disorder elicited by gluten in genetically 
susceptible individuals and characterized by the pres-
ence of a variable combination of gluten dependent 
clinical manifestations, CD-specific antibodies, human 
leukocyte antigen (HLA)-DQ2 or DQ8 haplotypes 
and enteropathy.
CD is considered one of the most common auto-
immune conditions with prevalence that vary from 
0,5%-1% in the general population of countries world-
wide(1, 3, 4, 5, 6). A study conducted in Portugal found 
a prevalence of  0,7%(2). Several studies reported an 
increasing prevalence of CD in the general population, 
related to the increasing recognition of the disease and 
the availability of serologic markers.
For initial testing, a quantitative test detecting 
total IgA and IgA antibody to human recombinant 
tissue transglutaminase (IgA-TTG) or identification 
of anti-endomysium antibodies (EMA) from a blood 
sample is recommended. Identification of  EMA is 
currently considered as the reference standard anti-
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body test for CD, however it can suffer inter-observer 
variability and is more expensive.
A small intestinal biopsy should be performed so as 
to clarify whether CD is present or not, but histological 
assessment may be omitted in symptomatic cases who 
have high IgA-TTG levels, EMA positi vity, and are 
HLA-DQ2 and/or DQ8 heterodimer positive(7).
More than 95% of CD patients share the HLA-
DQ2 heterodimer, either in the cis (encoded by 
HLA-DR3-DQA1*0501-DQB1*0201) or in the trans 
configuration (encoded by HLA DR11-DQA1*0505- 
DQB1*0301 / DR7- DQA1*0201 DQB1 0202) and 
most of the remainder have the HLA-DQ8 (encoded 
by DQA1*0301-DQB1*0302)(8). The presence of 
one chain of  the DQ2 heterodimer (DQA1*05 or 
DQB1*02, but not both) accounts for an increased 
risk of CD(8).
Typing for HLA-DQ2 and HLA-DQ8 is a useful 
tool to exclude CD or to make it very unlikely in case 
of a negative antibodies test result. HLA testing may 
be offered to asymptomatic at-risk groups to select 
them to further CD specific antibody testing.
CD testing is recommended in symptomatic pa-
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tients and in at-risk groups who account for a higher CD 
prevalence, such as autoimmune diseases (especially type 1 
diabetes and thyroiditis) IgA deficiency, some genetic syn-
dromes (Down, Turner and Williams syndrome) and first 
degree-relatives of celiac patients. Previous studies regarding 
screening of first degree relatives have shown prevalence of 
CD in the range of 2.8%-10%(1, 3, 5, 12, 15).
Madeira is an island of Portugal with 267,785 inhabitants, 
53,988 under the age of 18 years.
The objective of  the present study is to determine the 
prevalence of CD in a group of first degree relatives of celiac 
children, and to access the frequency of HLA-DQ2 and DQ8 
in CD patients and its affected relatives. To date, this is the 




A survey was conducted of 39 children with celiac disease 
with follow-up in the Pediatric outpatient’s clinic of Dr. Nélio 
Mendonça Hospital, the Hospital that gives assistance to the 
entire Island. HLA typing was performed in this population. 
The diagnosis of CD index patients was based on the Eu-
ropean Society for Pediatric Gastroenterology, Hepatology 
and Nutrition (ESPGHAN) guidelines for the diagnosis of 
celiac disease in children and adolescents(7).
First degree relatives of these 39 children were invited to 
undergo serological screen for CD, from September 2010 to 
October 2011. All first degree relatives were questioned with 
regards to the presence of CD related diseases (such as autoim-
mune thyroiditis, diabetes mellitus, Down syndrome), and pres-
ence of gastrointestinal or non-gastrointestinal symptoms of 
CD. All family members were on gluten-containing diet when 
serologic tests were performed. In all seropositive relatives, 
small intestinal biopsy and HLA typing was recommended.
The present study was approved by the Hospital Ethics 
Committee, according to the Declaration of  Helsinki. All 
subjects were informed about the objectives of the study and 
the eventual necessity for small bowel biopsy and genetic 
HLA typing. Informed consent was obtained from adults 
and from the parents of the siblings.
This study had the collaboration of the Laboratory of 
Human Genetics of the University of Madeira.
Serologic markers and small intestinal biopsy
The serologic screening was based on total IgA and 
IgA-TTG determined by chemiluminescent immunoassay in 
samples of human serum or plasma (EDTA, heparin), be-
ing 10 AU/mL the upper normal limit range determined by 
the manufacturer (ZENIT RA t-TG IgA test - A. Menarini 
diagnostics).
Small intestinal biopsy was performed by endoscopy 
procedure with two fragments being taken from the bulb and 
three or four samples from the distal duodenum.
All biopsy specimens were blindly evaluated by a patholo-
gist and classified according to Marsh-Oberhuber classifica-
tion(11) Briefly, type 0 lesion indicates normal histology; type 
I is characterized by an increased number of intraepithelial 
lymphocytes (greater than 30 limphocytes per 100 entero-
cytes) in an architecturally normal intestinal mucosa; type II 
presents crypt hyperplasia, but normal villi; finally type III 
is characterized by an increasing degree of villous atrophy, 
as (A) partial, (B) sub-total and (C) total villous atrophy.
Subjects classified with grade 3 were diagnosed as being 
affected by CD.
HLA-typing
All individuals were typed for HLA-DQA1 and HLA-
DQB1 in high resolution through nucleotide sequencing 
after amplification by polymerase chain reaction (PCR) from 
genomic DNA, extracted by salting out method(9). Following 
the methodology described by Rajalingam et al.(13), in order 
to sequence the HLA-DQA1 gene, it was necessary to make 
specific amplifications of  three groups of  alleles: group 1 
(HLA-DQA1 * 01), group 2 (HLA-DQA1 * 02, * 04, * 05 and 
* 06 ) and group 3 (HLA-DQA1 * 03)(13). For sequencing the 
HLA-DQB1, specific amplifications were made for two groups 
of alleles: the group consisting of HLA-DQB1 * 02, * 03 and 
* 04 and the group comprising HLA-DQB1 * 05 and * 06(16).
The amplification products were visualized after gel 
electrophoresis in 2% agarose and purified with Sephadex 
G-50 Fine (Amersham Biosciences). For sequencing reac-
tion, BigDye Terminator v3.1 Cycle Sequencing (Applied 
Biosystems) kit was used, and the sequencer ABI PRISM 
310 Genetic Analyzer (Applied Biosystems Applera, Foster 
City, CA) for reading the samples.
RESULTS
Characterization of pediatric CD population
Is important to note that this study was conducted at the 
only hospital that gives assistance to the island, therefore the 
results are representative of the island’s pediatric population.
Thirty-nine children with diagnosis of  CD were regis-
tered, 18/46% males and 21/54% females, age range 6 months 
to 17 years, median 6 years, with a median age of diagnosis 
of 22 months (Table 1).
TABLE 1. Sex, age and clinical characteristics of celiac disease patients 
at the time of diagnosis






0 to 6 months 2 5.1
7 to 12 months 11 28.2
13 to 24 months 19 48.7
More than 24 months 7 18.0
Clinical form at diagnosis
Gastrointestinal symptoms 39 100.0
Non-gastrointestinal symptoms* 27 69.2
* Non gastrointestinal symptoms in this group: faillure to thrive, anemia, neurologic symptoms
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The prevalence of CD in children under the age of 18 
years was 0,07%
CD related disorders were found in three patients - Down 
Syndrome, Diabetes mellitus type I, IgA deficiency, one case 
for each. 
HLA- typing was performed in 38 celiac patients, 28/74% 
DQ2 positive, 1/2% DQ8 positive and 9/24% incomplete DQ2 
(presence of only one allele - DQA1*05 or DQB1*02). One 
patient didn’t undergo HLA typing.
First degree relatives
Ninety-five first degree relatives (46/48% females, 49/51% 
males, age range 3-55 years, mean age 27,58 years) out of 
the 110 first degree relatives of the 39 CD children agreed 
with the screening procedure and, after obtaining informed 
consent, underwent serological testing.
This 95 relatives included 58 parents (27 fathers and 31 
mothers, aged 26-55 years, median 37,3 years) and 37 siblings 
(15 sisters and 22 brothers, aged 3 to 25, median 12 years).
Positive IgA-TGG was found in five relatives (two sisters, 
one brother, one father and one mother) age range 10 to 33. 
Three out of these five individuals had symptoms [abdominal 
distension (n = 2) and weight loss (n = 1)].
Three individuals (two siblings and a father) had the 
presence of HLA-DQ2, whereas two were DQ2 incomplete 
- DQB1*02 (one mother and one sister).
Histological changes characteristic of CD were found in 
three of these five first degree relatives [type 3A (one mother) 
(type 3B (2 siblings)]. One father refused the endoscopic bi-
opsy and one sister had normal intestinal mucosa. (Figure 1)
DISCUSSION
The prevalence of celiac disease in children varies consider-
ably, from 0.02% (Kuwait) to 1.0% in European countries like 
Great Britain and Finland(14). In the present study, the preva-
lence of CD in children under the age of 18 years was 0,07%.
The prevalence of  CD among the first degree relatives 
was 3,15% (approximately 1:31 relatives), 4.5 times higher 
than the proposed prevalence among the general Portuguese 
population (0,7%)(2) which reinforces the risk of first-degree 
relatives for CD in contrast to general population.
It is important to note that the fact that the study was 
conducted at the only hospital that gives assistance to Ma-
deiran population, gives strength to the study, since the data 
are representative of the island’s pediatric population.
Our results are similar to those found in Spain by Victoria 
et al.(15) that reported a prevalence of 2,8% new cases among 
642 first degree relatives of  celiac patients. In the recent 
studies the prevalence among first-degree relatives varied 
between 2.6% to 9.5%, a range that can be consequence of 
methodological differences used in these studies and the ge-
netic background of the distinct population valued(1, 2, 5, 14, 15). 
Interesting to notice that our results were similar to those 
from a recent study conducted in another Portuguese region 
(Porto) by Andreia Oliveira et al.(12) that revealed a prevalence 
of  2.6% among 268 first degree relatives. A lower genetic 
variability typical in island inhabitants may be responsible 
for the slight higher prevalence found in our study.
It is important to notice that one first degree relative was 
characterized as with a latent form of CD inasmuch as she 
had positive serologic and genetic markers, despite absence 
of  symptoms and normal intestinal mucosa. This patient 
will maintain follow up in order to assess future CD mani-
festations and intestinal mucosa lesions. The other relative 
who refused the intestinal biopsy is a potential CD patient, 
and the explanation of the risks of undiagnosed illness was 
given to the patient.
One out of the three positive relatives presented a silent 
form of CD which highlights the importance of screening all 
CD first degree relatives. The presence of one IgA deficiency 
child among the index cases is not surprising and corrobo-
rates the importance of assaying IgA levels for CD screening.
Every CD index cases carried HLA-DQ2 (complete or 
incomplete form) or DQ8 haplotype. The HLA-DQ2 hap-
lotype was the most prevalent according to other published 
studies(4, 8).
Each three relatives with CD also carried the HLA DQ2 
haplotype, reinforcing the diagnosis of CD.
There is only a small percentage of CD patients who are 
negative for HLA-DQ2 and DQ8, which makes this a good 
exclusion test. There is some evidence that HLADQ2/DQ8 
typing has a role in the case-finding strategy in individuals 
who belong to groups at risk of CD(7).
Obtaining biopsies from every first-degree relatives would 
have enabled us to establish the true prevalence of CD among 
them, but the invasiveness and cost of the test preclude the 
submission of all CD relatives to this examination. For this FIGURE 1. First degree relatives. Results
HLA: human leukocyte antigen
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reason serologic tests and HLA typing have an important 
role in screening potential patients.
Recent population-based studies have suggested that pa-
tients with diagnosed CD are at increased risk of mortality 
and increased risk of lymphoproliferative malignancy and 
gastrointestinal cancer. There is also some evidence suggest-
ing that a gluten free diet may reduce the risk of lymphop-
roliferative malignancy(9).
Hence, the acknowledgment that CD relatives are a 
population at high risk of  developing gluten intolerance, 
suggests the need for an extensive screening policy in order 
to prevent complications and improve the quality of life of 
these individuals.
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RESUMO - Contexto - A doença celíaca é uma doença sistémica autoimune muito prevalente nos familiares de primeiro grau de doentes celíacos. Obje-
tivos - O objetivo deste estudo é determinar a prevalência de doença celíaca, num grupo de familiares de primeiro grau de crianças com o diagnóstico 
de doença celíaca e, determinar a frequência de antígeno leucocitário humano (HLA)-DQ2 e DQ8 nos doentes celíacos e seus familiares afetados. 
Métodos - Foi feita a pesquisa dos processos clínicos de 39 crianças com o diagnóstico de doença celíaca seguidas na consulta de Gastroenterologia 
Pediátrica do Hospital Dr. Nélio Mendonça na Ilha da Madeira, Portugal. Foram convidados 110 familiares de primeiro grau para a realização do 
rastreio serológico de doença celíaca através da quantificação do anticorpo IgA anti-transglutaminase tecidular humano (IgA-TGG). Aos familiares 
com resultado positivo no rastreio, foi recomendada a realização de biópsia intestinal e tipificação HLA. Resultados - A tipificação HLA foi realizada 
em 38 crianças. Verificou-se a presença do heterodímero DQ2 em 28/74%, DQ8 em 1/2% e DQ2 incompleto em 9/24% das crianças. O rastreio de DC 
com IgA-TGG foi positivo em cinco dos 95 familiares analisados, tendo sido diagnosticada doença celíaca em três destes. Verificou-se a presença do 
heterodímero HLA-DQ2 em três familiares e HLA-DQ2 incompleto (DQB1*02) em dois familiares. Conclusões - A prevalência de doença celíaca 
em familiares de primeiro grau de doentes celíacos foi 3.1%, 4.5 vezes mais elevada do que a da população Portuguesa geral (0,7%), o que reforça a 
importância de alargar o rastreio a este grupo específico. A tipificação HLA pode constituir um instrumento importante na abordagem diagnóstica.
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